|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06160 BEONE MEDICINES
Nominal 
199.500 +0.800 (+0.403%) | 2026/06 - Interim USD(K$) | 2025/12 USD(K$) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 1,127,580 | (140,631) | (1,157,453) | (1,496,619) |
| Net Cash from / (used in) Investing Activities | -- | (276,155) | (548,350) | 60,004 | 1,077,123 |
| Net Cash from / (used in) Financing Activities | -- | 1,059,451 | 193,449 | 416,478 | (18,971) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,910,876 | (495,532) | (680,971) | (438,467) |
| Cash & Cash Equivalents at beginning of period | -- | 2,638,747 | 3,185,984 | 3,875,037 | 4,382,887 |
| Effect of Foreign Exchange Rate Changes | -- | 60,024 | (51,705) | (8,082) | (69,383) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 4,609,647 | 2,638,747 | 3,185,984 | 3,875,037 |
| Remarks: | Real time quote last updated: 06/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 464,364 |
| %Change | 385.787% |
| EPS / (LPS) | USD 0.320 |
| NBV Per Share ($) | USD 3.627 |